3861 results for «2519»
3861 results
Abstracts in TAVI
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to discover various abstracts in TAVI, such as: combination of malnutrition and muscle weakness deteriorates clinical outcomes after TAVR, 3D printed silicone casted TAVI training simulator, TAVR with the new balloon-expandable SAPIEN 3 Ultra vs. SAPIEN 3 valve system, and more!
Mitral and tricuspid valves: new technologies on the horizon
16 Feb 2020 – From PCR Tokyo Valves 2020
Learn about up-to-date data regarding new mitral and tricuspid percutaneous techniques and future repair technologies...
Imaging Day - Case-based echo imaging for the aortic valve
14 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn more about low-flow low-gradient aortic stenosis, and discover how to predict prothesis-patient mismatch and how to detect prosthetic valve thrombosis.
Cases in TAVI
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to discover various challenging TAVI cases, such as: subacute occlusion of right coronary artery after surgical aortic valve replacement, large post-myocardial infarction ventricular septum defect closure, NSTEMI after complex PCI and transfemoral TAVI procedure, and more!
Opening Ceremony - Tokyo Valves 2020
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to see the slides of PCR Tokyo Valves 2020 opening ceremony, learn more about PCR's mission, charter, companions, and discover what makes this course unique.
Abstracts from submissions - PCR Tokyo Valves 2020
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to read 3 of the abstracts submitted for PCR Tokyo Valves 2020: thrombocytopenia after transfemoral TAVI, current generation transcatheter aortic valves in patients with large aortic annuli, and TAVI with Evolut R vs. Sapien 3 in small aortic annulus.
Closing Ceremony - PCR Tokyo Valves 2020
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to see the slides of PCR Tokyo Valves 2020 closing ceremony, and discover who won the best clinical case and best abstract awards this year.
How should aortic stenosis be treated in the modern era and what is the role of the heart team?
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to gain insight into the current status of aortic stenosis treatment around the world, to learn more about the patient and treatment selection by the Heart Team, and to discover how the patient pathway's optimization may facilitate the increasing demand for TAVR.
PCR Tokyo Valves 2020: Selection of the 2020 best clinical cases
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to discover a selection of the best clinical cases presented during PCR Tokyo Valves 2020: unusual cause of coronary artery obstruction after TAVI, simultaneous TAVR-in-TAVR and valve-in-mitral-annular-calcification intervention, paravalvular leak with valve-in-valve TAVR and bioprosthetic ring fracturing, and more!
MitraClip case in point in Japanese
16 Feb 2020 – From PCR Tokyo Valves 2020
Find out more on the MitraClip NT System Japan post market surveillance, the MitraClip best practice and challenging functional MR cases...
Remaining challenges in TAVI: how to achieve the better lifetime outcomes for AS patients
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to gain insight into the remaining challenges in TAVI, such as providing AS patients with the best possible outcomes over their entire lifetime, improving pacemaker implant rates with self-expandable valves, and more!
Challenging cases on mitral interventions, TAVI and LAA closure
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to discover various challenging cases, such as: systolic anterior motion with mitral regurgitation triggered by TAVI, transcatheter mitral valve repair using MitraClip through atrial septal defect, ACS complicating transcaval TAVI, and more!
Abstracts in Japanese
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to discover a selection of abstracts submitted during PCR Tokyo Valves 2020, such as: impact of beta blockers on patients undergoing TAVR, predictive factors of no symptomatic improvement after TAVI, and more!
Challenging cases
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to discover challenging TAVI cases and high-risk procedures, regarding pulmonic valve stenosis and PPM, calcific aortic stenosis, degenerative aortic stenosis, and more. Watch it now to discover the chosen treatment!
TAVI and others
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn more about a study comparing the treatment's results of patients with bicuspid (BAV) and tricuspid aortic valve (TAV), in whom TAVI was performed, in terms of device success, early safety and clinical efficacy.
Complication cases
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn through a selection of complications cases how to manage transcatheter aortic valve migration, aorto-right ventricular fistula after TAVI, and sudden haemodynamic collapse during TAVI.
Challenging TAVI cases
18 May 2021 – From EuroPCR 2021
In this session, look at TAVR complications, study how to find a way to deliver an aortic valve prosthesis, and think about how to treat a failing tissue AVR in a fit 60 year-old doctor.
Dealing with shock
18 May 2021 – From EuroPCR 2021
Find out more about left main shock syndrome, always an unpredictable situation, and study the case of a STEMI patient with cardiogenic shock.
Challenging heart failure and mitral regurgitation cases
18 May 2021 – From EuroPCR 2021
In this session, analyze the cases of a young patient with multivessel coronary disease and severe heart failure, and a patient with heart failure, prior rigid mitral ring replacement, and severe mitral regurgitation.
Mitral valve challenges
18 May 2021 – From EuroPCR 2021
Watch this session to find out more about flail bioprosthetic mitral valve treatment, acute prosthetic mitral valve regurgitation, severe structural and non-structural mitral bioprosthesis degeneration, and severe left ventricular outflow tract obstruction after transcatheter mitral valve replacement
